PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Fortitech, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Steady Global Growth for Fortitech Fuels $22 Million in Capital Investments Over Three-Year Period - As part of its global commitment to strengthen customer service, client relations, and manufacturing/testing capabilities, Fortitech, Inc. announces several major expansions in the United States, Malaysia and Mexico
Steady Global Growth for Fortitech Fuels $22 Million in Capital Investments Over Three-Year Period

 

NewswireToday - /newswire/ - Schenectady, NY, United States, 2007/03/08 - As part of its global commitment to strengthen customer service, client relations, and manufacturing/testing capabilities, Fortitech, Inc. announces several major expansions in the United States, Malaysia and Mexico.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Fortitech, Inc. will be relocating its Fontana, California facility to a larger, state-of-the-art manufacturing and laboratory facility located in Ontario, California, about 14 miles from Fontana. Fortitech’s worldwide headquarter facility located in New York, will be adding 35,000 square feet of warehouse/manufacturing space to the existing 95,000 square foot facility. These expansions will make way for bigger blending capacities, enhanced technical capabilities, and increased customer service support.

Fortitech, Asia Pacific will be constructing a brand new, state-of-the-art manufacturing and laboratory facility located in Kuala Lumpur, Malaysia. This major investment will continue our commitment to serving custom nutrient premix demands globally and will position us to better serve rapidly growing markets such as China, Indonesia and Australia.

Also experiencing increased growth is Fortitech Mexico which will be relocating to a larger distribution office in southern Mexico City. The new location will be in closer proximity to the city’s business district and airport for enhanced commerce capabilities.

Overall, these new facilities and upgrades will cap off a more than $22 million global expansion which includes the company’s new manufacturing and testing facility in Gadstrup, Denmark, which opened in 2005. The Ontario, California facility is expected to open late this summer and the New York expansion is anticipated to be complete by this fall. Fortitech, Mexico will be transitioned by early spring and the brand new Malaysia plant is projected to be fully functional by 2008.

About Fortitech, Inc.
Founded in 1986, Fortitech, Inc. (fortitech.com) is the world leader in the development of custom nutrient premixes for the food, beverage and pharmaceutical industries, integrating functional ingredients from a comprehensive selection of vitamins, minerals, amino acids, nucleotides and nutraceuticals. Fortitech is ISO 9001:2000 and FPA certified and meets kosher and Halal standards. Headquartered in Schenectady, N.Y., the company has a global network of manufacturing and distribution facilities, throughout Europe, Asia Pacific, South America, Mexico and the United States (New York and California).

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Fortitech, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Steady Global Growth for Fortitech Fuels $22 Million in Capital Investments Over Three-Year Period

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Mark Fanion 
518-372-5155 fanion.mark[.]fortitech.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Fortitech, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Fortitech, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Intrinsic Executive Search Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)